Earnings calendar

Takeda Pharmaceutical Company Limited (TAK) earnings: date, estimates, results and stock reactions

Next earnings: Q3 FY2026 on 2027-01-28 (expected, after the close). EPS estimate 44.59, revenue estimate 1.20T.

Over the last 12 reports the stock moved 2.3% on average (either way), rising 6 times and falling 6. EPS beat estimates 8 of 12 times; revenue 8 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).

QuarterReportedEPSEPS estimateEPS surpriseRevenueRevenue estimateStock move
Q2 FY20262026-10-29121.2945.38+167.3%1.19T1.16T+5.5%
Q1 FY20262026-07-3071.6553.12+34.9%1.22T1.15T-5.7%
Q4 FY20252026-05-13-15.58-24.04+35.2%1.10T1.12T+1.7%
Q3 FY20252026-01-2964.9343.14+50.5%1.18T1.19T+3.1%
Q2 FY20252025-10-29-8.1621.61-137.8%1.11T1.21T-1.0%
Q1 FY20252025-07-2981.3850.79+60.2%1.11T1.20T-0.2%
Q4 FY20242025-05-07-64.14-8.59-646.6%1.05T1.04T-3.1%
Q3 FY20242025-01-3014.9225.86-42.3%1.14T1.12T+1.3%

TAK stock report · Earnings calendar